Geode Capital Management
THTX

Geode Capital Management’s Theratechnologies THTX Stock Holding History

Geode Capital Management’s Portfolio THTX Stock Details THTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23,971
Closed -$56.6K – 4564
2025
Q2 		$56.6K Sell
23,971
-1,710
-7% -$4.19K ﹤0.01% 4188
2025
Q1 		$36K Hold
25,681
– – ﹤0.01% 4253
2024
Q4 		$46.5K Hold
25,681
– – ﹤0.01% 4255
2024
Q3 		$31.6K Hold
25,681
– – ﹤0.01% 4346
2024
Q2 		$36.5K Hold
25,681
– – ﹤0.01% 4343
2024
Q1 		$41.9K Hold
25,681
– – ﹤0.01% 4356
2023
Q4 		$41.6K Buy
25,681
+12,804
+99% +$19.3K ﹤0.01% 4395
2023
Q3 		$27.7K Buy
+12,877
New +$27.6K ﹤0.01% 4557

Other funds holding THTX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CWP
Cyndeo Wealth Partners St. Petersburg, Florida $1.9B AUM 24.89% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIP
Greatmark Investment Partners Columbus, Georgia $854M AUM 15.72% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM

Geode Capital Management's THTX Position: Q3 2025 in Review

Geode Capital Management sold out of Theratechnologies (THTX) in Q3 2025, closing a stake of 23,971 shares — an estimated $56.6K sold.

Geode Capital Management first reported a position in THTX in Q3 2023 and held it in 8 quarters. The position peaked at $56.6K in Q2 2025. 10 funds tracked by Wall St. Rank hold THTX as of Q3 2025.

  • Geode Capital Management reported no remaining Theratechnologies position as of Q3 2025 after selling out during the quarter.
  • Geode Capital Management sold 23,971 Theratechnologies shares in Q3 2025, an estimated $56.6K.
  • Geode Capital Management first reported a position in Theratechnologies in Q3 2023 and held it in 8 quarters.
  • Geode Capital Management's Theratechnologies position peaked at $56.6K in Q2 2025.
  • 10 funds tracked by Wall St. Rank held Theratechnologies as of Q3 2025.

Based on Geode Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.